Ovid Therapeutics Inc. (NASDAQ:OVID) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. lowered its position in shares of Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) by 3.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,418,306 shares of the company’s stock after selling 45,532 shares during the quarter. JPMorgan Chase & Co.’s holdings in […]
JPMorgan Chase & Co. lowered its position in shares of Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) by 3.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,418,306 shares of the company’s stock after selling 45,532 shares during the quarter. JPMorgan Chase & Co.’s holdings in […]
